Japanese encephalitis.
ICD-10 A85.1 is a billable code used to indicate a diagnosis of japanese encephalitis..
Japanese encephalitis (JE) is a viral infection caused by the Japanese encephalitis virus (JEV), primarily transmitted through the bite of infected mosquitoes, particularly in rural agricultural areas of Asia. The disease is characterized by inflammation of the brain, leading to neurological complications that can range from mild to severe. Symptoms typically begin with fever, headache, and vomiting, progressing to neurological manifestations such as seizures, altered consciousness, and paralysis. The incidence of JE is highest in children under 15 years of age, and while many infections are asymptomatic, a significant proportion can lead to severe neurological impairment or death. Vaccination is the most effective preventive measure, especially for individuals living in or traveling to endemic areas. The vaccine is recommended for those at high risk, including travelers and residents in areas where JE is prevalent. Early diagnosis and supportive care are crucial for improving outcomes, as there is no specific antiviral treatment for the infection. Understanding the clinical presentation and vaccination status is essential for accurate coding and management of this condition.
Detailed travel history, vaccination records, and clinical findings.
Patients presenting with fever and neurological symptoms after travel to endemic areas.
Ensure vaccination status is clearly documented to support coding.
Comprehensive neurological examination and imaging results.
Patients with acute encephalitis symptoms requiring neurological assessment.
Document all neurological deficits and complications for accurate coding.
Used to confirm diagnosis in suspected cases.
Document the reason for testing and clinical findings.
Infectious disease specialists should ensure comprehensive history is included.
Symptoms include fever, headache, vomiting, seizures, and altered consciousness. Severe cases can lead to neurological complications.
Diagnosis is typically made through clinical evaluation and confirmed with serological tests or PCR for the virus.
Yes, there is a vaccine available, and it is recommended for individuals traveling to or living in endemic areas.
